| positive regulation of t cell mediated cytotoxicity | GO:0001916 | 15 | 1.000 | |
| regulation of tolerance induction dependent upon immune response | GO:0002652 | 1 | 1.000 | |
| negative regulation of natural killer cell mediated immunity | GO:0002716 | 5 | 0.998 | |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.997 | |
| antigen processing and presentation via mhc class ib | GO:0002475 | 8 | 0.996 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.986 | |
| iron ion import into cell | GO:0097459 | 4 | 0.983 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway | GO:0002484 | 3 | 0.983 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib | GO:0002476 | 4 | 0.981 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.943 | |
| regulation of natural killer cell mediated immunity | GO:0002715 | 19 | 0.941 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.929 | |
| positive regulation of tolerance induction dependent upon immune response | GO:0002654 | 1 | 0.916 | |
| antigen processing and presentation of peptide antigen via mhc class ib | GO:0002428 | 5 | 0.913 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.898 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.894 | |
| regulation of cell killing | GO:0031341 | 40 | 0.889 | |
| positive regulation of t cell mediated immunity | GO:0002711 | 24 | 0.859 | |
| positive regulation of cell killing | GO:0031343 | 33 | 0.850 | |
| antigen processing and presentation of peptide antigen | GO:0048002 | 29 | 0.826 | |
| regulation of defense response | GO:0031347 | 233 | 0.822 | |
| regulation of t cell mediated immunity | GO:0002709 | 34 | 0.821 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.767 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway tap dependent | GO:0002489 | 2 | 0.742 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i | GO:0019885 | 3 | 0.738 | |
| innate immune response | GO:0045087 | 157 | 0.736 | |
| antigen processing and presentation of peptide antigen via mhc class i | GO:0002474 | 9 | 0.733 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.724 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.723 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class ib | GO:0002477 | 3 | 0.722 | |
| defense response to other organism | GO:0098542 | 197 | 0.699 | |
| tolerance induction dependent upon immune response | GO:0002461 | 1 | 0.641 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.607 | |
| response to protozoan | GO:0001562 | 28 | 0.587 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.585 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.582 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.581 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.576 | |
| antigen processing and presentation of exogenous peptide antigen | GO:0002478 | 21 | 0.575 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway tap dependent | GO:0002485 | 3 | 0.540 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.522 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.515 | |
| adaptive immune response | GO:0002250 | 155 | 0.510 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.508 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.497 | |
| cell killing | GO:0001906 | 67 | 0.495 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.492 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.491 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.439 | |
| cytokine production | GO:0001816 | 319 | 0.429 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.420 | |
| antigen processing and presentation of endogenous peptide antigen | GO:0002483 | 6 | 0.414 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.414 | |
| immune effector process | GO:0002252 | 321 | 0.407 | |
| antigen processing and presentation of exogenous antigen | GO:0019884 | 26 | 0.406 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.395 | |
| cation transport | GO:0006812 | 399 | 0.393 | |
| defense response to bacterium | GO:0042742 | 119 | 0.391 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.386 | |
| antigen processing and presentation of endogenous antigen | GO:0019883 | 6 | 0.381 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.380 | |
| transition metal ion transport | GO:0000041 | 38 | 0.374 | |
| import into cell | GO:0098657 | 8 | 0.366 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.365 | |
| interferon gamma production | GO:0032609 | 67 | 0.364 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.360 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.356 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.346 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.345 | |
| interleukin 17 production | GO:0032620 | 11 | 0.321 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.310 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.304 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.297 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.296 | |
| negative regulation of innate immune response | GO:0045824 | 17 | 0.271 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.270 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.259 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.259 | |
| positive regulation of tolerance induction | GO:0002645 | 8 | 0.251 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway | GO:0002488 | 2 | 0.244 | |
| ear development | GO:0043583 | 200 | 0.242 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.238 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.232 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.225 | |
| inorganic cation import into cell | GO:0098659 | 4 | 0.218 | |
| interleukin 1 production | GO:0032612 | 31 | 0.213 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.197 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.191 | |
| adhesion of symbiont to host | GO:0044406 | 8 | 0.190 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.188 | |
| positive regulation of natural killer cell mediated cytotoxicity | GO:0045954 | 16 | 0.187 | |
| multicellular organismal iron ion homeostasis | GO:0060586 | 8 | 0.181 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.172 | |
| t cell tolerance induction | GO:0002517 | 6 | 0.172 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.172 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.169 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.158 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.151 | |
| defense response to virus | GO:0051607 | 68 | 0.146 | |
| positive regulation of nitric oxide biosynthetic process | GO:0045429 | 14 | 0.142 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.136 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.135 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.133 | |
| cation homeostasis | GO:0055080 | 212 | 0.131 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.126 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.121 | |
| antigen processing and presentation of exogenous protein antigen via mhc class ib tap dependent | GO:0002481 | 3 | 0.119 | |
| regulation of nitric oxide biosynthetic process | GO:0045428 | 18 | 0.117 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.112 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.111 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.109 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class i | GO:0042590 | 6 | 0.108 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.106 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.106 | |
| t cell activation | GO:0042110 | 289 | 0.105 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.103 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.101 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.099 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.096 | |
| nitric oxide metabolic process | GO:0046209 | 25 | 0.096 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.095 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.094 | |
| negative regulation of lymphocyte mediated immunity | GO:0002707 | 21 | 0.093 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.093 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.092 | |
| gtp catabolic process | GO:0006184 | 143 | 0.087 | |
| regulation of type i interferon production | GO:0032479 | 22 | 0.082 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.082 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.081 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.080 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.079 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.079 | |
| gtp metabolic process | GO:0046039 | 144 | 0.077 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.076 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.076 | |
| hormone biosynthetic process | GO:0042446 | 16 | 0.075 | |
| negative regulation of intracellular protein transport | GO:0090317 | 27 | 0.072 | |
| hormone metabolic process | GO:0042445 | 86 | 0.072 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.072 | |
| tolerance induction | GO:0002507 | 14 | 0.070 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.068 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.065 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.065 | |
| nitric oxide biosynthetic process | GO:0006809 | 25 | 0.063 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.063 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.063 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.062 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.062 | |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.061 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.060 | |
| response to interferon gamma | GO:0034341 | 34 | 0.060 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.060 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.059 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.058 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.056 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.055 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.055 | |
| negative regulation of natural killer cell mediated cytotoxicity | GO:0045953 | 5 | 0.054 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.053 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.053 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.053 | |
| defense response to protozoan | GO:0042832 | 25 | 0.052 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.051 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.051 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.050 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.050 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.050 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.048 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.047 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.047 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.047 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.047 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.046 | |
| protein ubiquitination | GO:0016567 | 171 | 0.046 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.045 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.045 | |
| response to interferon beta | GO:0035456 | 22 | 0.044 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.044 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.044 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.043 | |
| regulation of tolerance induction | GO:0002643 | 10 | 0.043 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.043 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.042 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.042 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.040 | |
| cellular response to lipid | GO:0071396 | 145 | 0.040 | |
| regulation of interferon alpha production | GO:0032647 | 5 | 0.040 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.039 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.039 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.038 | |
| negative regulation of defense response to virus by host | GO:0050689 | 1 | 0.038 | |
| protein refolding | GO:0042026 | 1 | 0.037 | |
| iron ion transport | GO:0006826 | 17 | 0.037 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.036 | |
| protein import | GO:0017038 | 101 | 0.036 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.035 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.034 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.034 | |
| viral life cycle | GO:0019058 | 36 | 0.033 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| protein localization to organelle | GO:0033365 | 185 | 0.032 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.031 | |
| neutrophil mediated killing of gram negative bacterium | GO:0070945 | 4 | 0.030 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.030 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.030 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.029 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.029 | |
| negative regulation of interferon beta biosynthetic process | GO:0045358 | 1 | 0.029 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.029 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.029 | |
| rna interference | GO:0016246 | 2 | 0.028 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.028 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.028 | |
| protein import into nucleus | GO:0006606 | 95 | 0.028 | |
| negative regulation of nucleocytoplasmic transport | GO:0046823 | 23 | 0.028 | |
| type i interferon production | GO:0032606 | 29 | 0.028 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.027 | |
| inflammatory response | GO:0006954 | 244 | 0.027 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.027 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.027 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.026 | |
| cell adhesion | GO:0007155 | 329 | 0.025 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.025 | |
| intracellular protein transport | GO:0006886 | 204 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.025 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.025 | |
| maintenance of location | GO:0051235 | 89 | 0.024 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.024 | |
| protein targeting | GO:0006605 | 143 | 0.024 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.023 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.023 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.023 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.022 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.022 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.021 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.021 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.021 | |
| inorganic ion import into cell | GO:0099587 | 4 | 0.021 | |
| ossification | GO:0001503 | 216 | 0.021 | |
| regulation of protein localization | GO:0032880 | 231 | 0.021 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.021 | |
| muscle cell development | GO:0055001 | 133 | 0.020 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.020 | |
| developmental maturation | GO:0021700 | 193 | 0.020 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.020 | |
| negative regulation of cell killing | GO:0031342 | 8 | 0.019 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.019 | |
| negative regulation of toll like receptor signaling pathway | GO:0034122 | 14 | 0.019 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.019 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.018 | |
| negative regulation of interferon alpha production | GO:0032687 | 1 | 0.018 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.018 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.018 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.018 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.018 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.018 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.018 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.017 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.017 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.017 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.017 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.017 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.017 | |
| tissue homeostasis | GO:0001894 | 115 | 0.017 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.017 | |
| regulation of defense response to fungus | GO:1900150 | 1 | 0.017 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.017 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.017 | |
| amine metabolic process | GO:0009308 | 45 | 0.016 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.016 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.016 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.016 | |
| muscle tissue development | GO:0060537 | 308 | 0.016 | |
| regulation of autophagy | GO:0010506 | 30 | 0.016 | |
| regulation of protein transport | GO:0051223 | 163 | 0.016 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.016 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.015 | |
| cellular response to type i interferon | GO:0071357 | 10 | 0.015 | |
| regulation of cd8 positive alpha beta t cell activation | GO:2001185 | 3 | 0.015 | |
| response to drug | GO:0042493 | 75 | 0.015 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.015 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.015 | |
| amide transport | GO:0042886 | 138 | 0.015 | |
| negative regulation of protein ubiquitination | GO:0031397 | 19 | 0.015 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.015 | |
| myotube differentiation | GO:0014902 | 105 | 0.015 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| cellular homeostasis | GO:0019725 | 240 | 0.015 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.015 | |
| response to amino acid | GO:0043200 | 37 | 0.015 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.014 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.014 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.014 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.014 | |
| protein catabolic process | GO:0030163 | 221 | 0.014 | |
| regulation of ion transport | GO:0043269 | 215 | 0.014 | |
| nuclear transport | GO:0051169 | 139 | 0.014 | |
| glucose homeostasis | GO:0042593 | 128 | 0.014 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.014 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.014 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.013 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.013 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.013 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.013 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.013 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.013 | |
| protein maturation | GO:0051604 | 176 | 0.013 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.013 | |
| regulation of neutrophil mediated killing of symbiont cell | GO:0070949 | 2 | 0.013 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.013 | |
| negative regulation of intracellular transport | GO:0032387 | 38 | 0.013 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.013 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.013 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.013 | |
| regulation of secretion | GO:0051046 | 274 | 0.013 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.012 | |
| protein methylation | GO:0006479 | 81 | 0.012 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.012 | |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.012 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.012 | |
| negative regulation of cytoplasmic transport | GO:1903650 | 29 | 0.012 | |
| lysosomal transport | GO:0007041 | 10 | 0.012 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.012 | |
| single organism nuclear import | GO:1902593 | 95 | 0.012 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.012 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.012 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.012 | |
| myosin filament organization | GO:0031033 | 3 | 0.012 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.012 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.012 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.012 | |
| response to inorganic substance | GO:0010035 | 96 | 0.012 | |
| activation of innate immune response | GO:0002218 | 56 | 0.012 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.011 | |
| positive regulation of antimicrobial humoral response | GO:0002760 | 2 | 0.011 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.011 | |
| macromolecule methylation | GO:0043414 | 120 | 0.011 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.011 | |
| disruption of cells of other organism involved in symbiotic interaction | GO:0051818 | 13 | 0.011 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.011 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.011 | |
| nuclear import | GO:0051170 | 95 | 0.011 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.011 | |
| viral transcription | GO:0019083 | 3 | 0.011 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.011 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.011 | |
| autophagy | GO:0006914 | 45 | 0.011 | |
| response to acid chemical | GO:0001101 | 111 | 0.011 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.011 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.011 | |
| t cell differentiation | GO:0030217 | 174 | 0.011 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.011 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.011 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.011 | |
| regulation of type i interferon mediated signaling pathway | GO:0060338 | 7 | 0.011 | |
| regulation of cell migration | GO:0030334 | 219 | 0.010 | |
| peptide secretion | GO:0002790 | 114 | 0.010 | |
| calcium ion transport | GO:0006816 | 159 | 0.010 | |
| muscle fiber development | GO:0048747 | 76 | 0.010 | |
| female sex differentiation | GO:0046660 | 84 | 0.010 | |
| angiogenesis | GO:0001525 | 201 | 0.010 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.010 | |
| regulation of ossification | GO:0030278 | 112 | 0.010 | |
| histone modification | GO:0016570 | 159 | 0.010 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.010 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.010 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.010 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.010 | |
| insulin secretion | GO:0030073 | 89 | 0.010 | |
